Derivatives of quinazoline

• US 3,266,990 A
• Filed: 09/24/1963
• Issued: 08/16/1966
• Est. Priority Date: 09/24/1963
• Status: Expired due to Term

• Current Assignee: Robert I. Meltzer, Wilson B. Lutz
• Original Assignee: Robert I. Meltzer, Wilson B. Lutz
• Inventors: Lutz, Wilson B., Meltzer, Robert I.
• Application Number:
  US04/311,209
• Time in Patent Office: 1,057 Days
• US Class Current: 514/266.1
• CPC Class Codes: A61K 31/505 Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
• CPC Class Codes: C07D 239/74 with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring

Claims

1. A COMPOUND OF THE FORMULA:

10. A HYPOTENSIVE COMPOSITION COMPRISING AS ACTIVE INGREDIENT OF ABOUT 1 TO 100 MG. A COMPOUND SELECTED FROM THE GROUP CONSISTING OF 4-(3,4-DIMETHOXYBENZYL)6,7-DIMETHOXYQUINAZOLINE AND THE PHARMACEUTICALLY ACCEPTABLE NONTOXIC ACID ADDITION SALT THEREOF AND A NONTOXIC INERT PHARMACEUTICAL CARRIER.